Literature DB >> 4019571

Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancer.

A Ardizzoni, P Pronzato, L Canobbio, R Lionetto, R Rosso.   

Abstract

Mitomycin plus vindesine have been utilized as salvage therapy in metastatic breast cancer patients refractory to first line chemotherapy. No response was observed in 15 consecutively evaluable patients; according to the Gehan test a lack of effectiveness of this regimen is suggested at least in heavily pretreated patients.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4019571     DOI： 10.1007/bf00402506

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  6 in total

1.  The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent.

Authors:  E A GEHAN
Journal:  J Chronic Dis       Date:  1961-04

2.  A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study.

Authors:  A T van Oosterom; T J Powles; E Hamersma; I E Smith; E Engelsman
Journal:  Eur J Cancer       Date:  1980       Impact factor: 9.162

3.  Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.

Authors:  H S Garewal; R J Brooks; S E Jones; T P Miller
Journal:  J Clin Oncol       Date:  1983-12       Impact factor: 44.544

4.  Phase II study of vindesine in patients with metastatic breast cancer.

Authors:  M A Cobleigh; S D Williams; L H Einhorn
Journal:  Cancer Treat Rep       Date:  1981 Jul-Aug

5.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

Review 6.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.